DeoxIT Shield, S5S-6, 5% Spray

Hazard statements (CLP)

H223

Code

Statements

H223

Flammable aerosol

SECTION 2: Hazards identification

This product is classified as a HAZARDOUS SUBSTANCE but not as DANGEROUS GOODS according to the classification criteria of NOHSC: 1008(2004) and ADG Code (Australia). WARNING! Flammable aerosol. Colorless, volatile liquid with ethereal and faint sweetish odor. Overexposure may cause dizziness and loss of concentration. At higher levels, CNS depression and cardiac arrhythmia may result from exposure. Vapors displace air and can cause asphyxiation in confined spaces.

Hazard statements

H) H223 – Flammable aerosol

Precautionary statements

P210 – Keep away from heat/sparks/open flames/hot surfaces. P211 – Do not spray on an open flame or other ignition source. P251 – Pressurized container. Do not pierce or burn, even after use. P280 – Wear protective gloves and eyewear. P302 + P352 – IF ON SKIN – Wash with plenty of soap and water. P312 – Call a Poison Control Center or doctor/physician if you feel unwell. P333 + P313 – If skin irritation or rash occurs, get medical advise/attention. P321 – Refer to section 4 of this Safety Data Sheet (First Aid). P305+P351+P338 – IF IN EYES - Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. P501 – Dispose of contents/container through licensed treatment, storage or disposal facility. Routes of Entry: Inhalation: YES Absorption: YES Ingestion: YES Effects of Exposure: EYES: Mild to moderate irritation. SKIN: Irritant and potential skin sensitizer. Prolonged or repeated contact may cause contact dermatitis (localized redness or rash). INGESTION: Gastrointestinal irritation and central nervous system depression. INHALATION: Central nervous system depressant. Irritating to the upper respiratory tract. 2.4 Symptoms of Overexposure: EYES: Mild irritation, redness, and watering. SKIN: Contact dermatitis, characterized by localized red or puffy dry skin and itching. INGESTION: Nausea, vomiting, and diarrhea. INHALATION: Mouth, nose, and throat irritation, dizziness, nausea, light-headedness, drunkenness, and loss of coordination. 2.5

Potential Acute Health Effects

INGESTION: Gastrointestinal irritation and central nervous system depression. EYES: Mild to moderate irritation. SKIN: Irritant and potential skin sensitizer. Prolonged or repeated contact may cause contact dermatitis (e.g., localized redness and/or rash). INGESTION: Gastrointestinal irritation and central nervous system depression. INHALATION: Central nervous system depressant. Irritating to the upper respiratory tract. 2.6

Potential chronic health

EYES: Mild to moderate irritation. SKIN: Irritant and potential skin sensitizer. Prolonged or repeated contact may cause contact dermatitis (e.g., localized redness and/or rash). INGESTION: Gastrointestinal irritation and central nervous system depression. INHALATION: Central nervous system depressant. Irritating to the upper respiratory tract. 2.7 Target Organs: Eyes, skin and respiratory system. NA = Not Available; ND = Not Determined; NE = Not Established; C = Ceiling Limit; See Section 16 for Additional Definitions of Terms Used NOTE: all WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-2010 format.